The construction of the first full-scale pyrolysis plant in Uddevalla is ongoing, but due to decided measures to improve the industrialization of the facility, the project timeline will be extended. A ...
DJ PTA-News: Trade & Value AG: Nettoinventarwert 2025-10 Unternehmensmitteilung für den Kapitalmarkt Trade & Value AG: Nettoinventarwert 2025-10 München, den 14.11.2025 (pta000/14.11.2025/16:05 ...
Heidelberg (ots) - - Umsatz nach sechs Monaten um rund 8 Prozent gegenüber dem Vorjahreszeitraum gesteigert - Bereinigtes operatives Ergebnis (EBITDA) hat sich gegenüber Vorjahr verdoppelt - Zukunftsp ...
Aeluma, Inc. (NASDAQ: ALMU) ("Aeluma" or the "Company"), a transformative semiconductor company specializing in high-performance and scalable technologies ...
EQS-News: LR Health & Beauty SE / Schlagwort(e): Anleihe LR Health & Beauty SE leitet ein Written Procedure im Rahmen seiner ausstehenden Anleihe 2024/2028 ein 14.11.2025 ...
Mitteilung der PCC SE: PCC erreicht im dritten Quartal Ergebniszuwächse trotz herausforderndem Marktumfeld - PCC-Gruppe mit mehr als verdreifachtem Quartals-EBITDA und positivem operativen Ergebnis Di ...
First United Corporation (NASDAQ: FUNC) and First United Bank & Trust today announced that Carissa L. Rodeheaver, Chairman ...
MySize, Inc. (NASDAQ: MYSZ), a global provider of AI-driven sizing solutions, footwear fit-tech, and retail innovation ...
Safe and Green Development Corporation (NASDAQ: SGD) ("SGD," the "Company," or "Safe and Green Development") today announced financial results for the three and ...
The share capital of Solar A/S has been increased due to completion of an accelerated bookbuilding process. The admittance to trading and official listing will take effect as of 17 November 2025 in ...
Returned to Profitability with Net Income of $0.2MThird Consecutive Quarter of Positive Adjusted EBITDARevenue Rises to $5.9M, with AI Integration and Cost Controls Driving Efficiency BOCA RATON, Fla.
Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trialAdvanced DRP® platform through ...